marketcaparena

ASTH

Astrana Health, Inc.

Company overview

Market capitalization
$1.96B
Employees
3,000
Latest publication
2026-09-29
About Astrana Health, Inc.

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ1 20232023-03-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USD
Total Revenue950,526,000USD956,048,000USD654,808,000USD620,390,000USD665,209,000USD337,244,000USD317,001,000USD269,697,000USD
Cost Of Revenue871,884,000USD874,451,000USD576,839,000USD549,061,000USD602,193,000USD289,397,000USD240,768,000USD230,070,000USD
Gross Profit78,642,000USD81,597,000USD77,969,000USD71,329,000USD63,016,000USD47,847,000USD76,233,000USD39,627,000USD
Selling General Administrative9,522,000USD113,112,000USD50,725,000USD43,897,000USD41,633,000USD21,182,000USD21,388,000USD19,894,000USD
Unclassified Operating Expenses50,725,000USD-50,725,000USD6,904,000USD6,849,000USD20,663,000USD4,292,000USD4,754,000USD4,351,000USD
Total Operating Expenses60,247,000USD62,387,000USD57,629,000USD50,746,000USD62,296,000USD25,474,000USD26,142,000USD24,245,000USD
Operating Income18,395,000USD19,210,000USD20,340,000USD20,583,000USD720,000USD22,373,000USD50,091,000USD15,382,000USD
Interest Income3,987,000USD3,522,000USD2,336,000USD2,312,000USD3,221,000USD3,009,000USD223,000USD421,000USD
Interest Expense17,520,000USD17,718,000USD7,382,000USD7,308,000USD8,069,000USD3,269,000USD2,422,000USD1,854,000USD
Net Interest Income-13,533,000USD-14,196,000USD-5,046,000USD-4,996,000USD-4,848,000USD-260,000USD-2,199,000USD-1,433,000USD
Income Before Tax7,506,000USD5,671,000USD16,825,000USD9,604,000USD-1,895,000USD19,409,000USD41,263,000USD16,629,000USD
Income Tax Expense944,000USD4,594,000USD6,609,000USD3,383,000USD5,882,000USD6,921,000USD17,366,000USD5,352,000USD
Tax Provision944,000USD4,594,000USD6,609,000USD3,383,000USD5,882,000USD5,102,000USD13,867,000USD6,038,000USD
Net Income5,999,000USD373,000USD9,423,000USD6,692,000USD-6,951,000USD13,132,000USD23,185,000USD11,950,000USD
Net Income From Continuing Ops6,562,000USD1,077,000USD10,216,000USD6,221,000USD-7,777,000USD14,307,000USD27,396,000USD10,591,000USD
Ebit25,026,000USD23,389,000USD24,207,000USD16,912,000USD6,174,000USD22,678,000USD43,685,000USD18,483,000USD
Ebitda41,427,000USD38,984,000USD31,111,000USD23,761,000USD14,300,000USD26,970,000USD48,440,000USD22,834,000USD
Depreciation And Amortization16,401,000USD15,595,000USD6,904,000USD6,849,000USD8,126,000USD4,292,000USD4,755,000USD4,351,000USD
Reconciled Depreciation16,401,000USD15,596,000USD6,903,000USD6,849,000USD8,126,000USD4,292,000USD4,754,000USD4,351,000USD
Total Other Income Expense Net-10,889,000USD-13,539,000USD-3,515,000USD-10,979,000USD-2,615,000USD-2,964,000USD-8,828,000USD1,247,000USD
Minority Interest-563,000USD-704,000USD-793,000USD471,000USD826,000USD-315,000USD1,410,000USD-808,000USD
Non Operating Income Net Other—————305,000USD-6,406,000USD3,101,000USD
Net Income Applicable To Common Shares—————14,622,000USD25,986,000USD11,399,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20222022-12-31 · USDFY 20142014-12-31 · USDFY 20112011-12-31 · USDFY 20102010-12-31 · USDFY 20092009-12-31 · USDFY 20082008-12-31 · USDFY 20072007-12-31 · USDFY 20062006-12-31 · USD
Total Revenue1,144,163,000USD32,989,742USD5,110,806USD3,896,584USD2,441,452USD1,057,354USD100,000USD—
Cost Of Revenue944,685,000USD22,067,421USD4,132,399USD3,314,722USD1,813,944USD1,046,103USD100,000USD—
Gross Profit199,478,000USD10,922,321USD978,407USD581,862USD627,508USD11,251USD——
Selling General Administrative77,670,000USD11,282,221USD1,379,153USD566,649USD694,319USD827,287USD36,651USD27,484USD
Unclassified Operating Expenses17,543,000USD———————
Total Operating Expenses95,213,000USD11,616,655USD1,391,742USD577,847USD730,023USD847,067USD36,651USD27,484USD
Operating Income104,265,000USD-694,334USD-413,335USD4,015USD-102,515USD-835,816USD-36,651USD-27,484USD
Interest Income1,976,000USD———————
Interest Expense7,920,000USD0USD304,034USD126,431USD53,128USD55,200USD36,651USD27,484USD
Net Interest Income-5,944,000USD———————
Income Before Tax86,616,000USD-1,184,165USD-714,527USD-154,731USD-195,280USD-891,015USD-36,651USD-27,484USD
Income Tax Expense40,875,000USD163,792USD5,819USD1,600USD800USD800USD36,651USD27,484USD
Tax Provision36,085,000USD———————
Net Income45,171,000USD-1,802,601USD-720,346USD-156,331USD-196,080USD-891,815USD-36,651USD-27,484USD
Net Income From Continuing Ops50,531,000USD-1,347,957USD-720,346USD—————
Ebit94,536,000USD-694,334USD-410,493USD4,015USD-102,514USD-835,815USD-36,651USD-27,484USD
Ebitda112,079,000USD-359,900USD-397,904USD15,213USD-66,811USD-816,035USD-36,651USD-27,484USD
Depreciation And Amortization17,543,000USD334,434USD12,589USD11,198USD35,703USD19,780USD——
Reconciled Depreciation17,543,000USD———————
Total Other Income Expense Net-17,649,000USD836,576USD2,842USD-32,315USD-39,637USD-46,250USD36,651USD27,484USD
Non Operating Income Net Other-9,729,000USD836,576USD-169,658USD—————
Minority Interest1,482,000USD454,644USD——————
Net Income Applicable To Common Shares49,049,000USD-1,802,601USD-720,346USD—————
Research Development—0USD0USD—————
Other Operating Expenses——————36,651USD27,484USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Assets2,358,827,000USD2,218,661,000USD2,237,186,000USD1,442,350,000USD1,331,256,000USD1,354,894,000USD1,285,376,000USD1,252,471,000USD
Intangible Assets257,118,000USD270,968,000USD285,060,000USD105,737,000USD111,916,000USD118,179,000USD109,108,000USD116,231,000USD
Other Current Assets25,647,000USD26,264,000USD23,162,000USD21,754,000USD23,711,000USD22,861,000USD20,506,000USD16,217,000USD
Total Liab1,781,371,000USD1,660,327,000USD1,682,462,000USD904,404,000USD813,550,000USD840,726,000USD778,269,000USD773,775,000USD
Total Stockholder Equity800,268,000USD779,291,000USD775,543,000USD765,461,000USD745,368,000USD712,720,000USD704,616,000USD678,874,000USD
Other Current Liab633,112,000USD512,098,000USD516,385,000USD427,598,000USD327,721,000USD333,555,000USD252,979,000USD246,511,000USD
Common Stock49,000USD49,000USD49,000USD49,000USD49,000USD48,000USD48,000USD48,000USD
Capital Stock49,000USD49,000USD49,000USD49,000USD49,000USD48,000USD48,000USD48,000USD
Retained Earnings322,711,000USD308,379,000USD302,486,000USD302,209,000USD292,880,000USD286,283,000USD293,234,000USD277,140,000USD
Good Will874,799,000USD863,944,000USD863,266,000USD416,917,000USD416,386,000USD419,253,000USD409,711,000USD409,581,000USD
Cash478,383,000USD429,474,000USD462,227,000USD339,703,000USD258,517,000USD288,455,000USD347,994,000USD325,310,000USD
Cash And Short Term Investments478,383,000USD429,474,000USD463,448,000USD342,120,000USD260,914,000USD290,833,000USD350,348,000USD327,693,000USD
Total Current Assets1,004,100,000USD863,313,000USD883,629,000USD729,152,000USD613,270,000USD638,496,000USD596,990,000USD569,149,000USD
Total Current Liabilities745,369,000USD615,273,000USD629,930,000USD459,746,000USD361,268,000USD365,608,000USD312,928,000USD309,825,000USD
Net Debt586,809,000USD648,656,000USD625,016,000USD107,887,000USD192,833,000USD183,384,000USD127,825,000USD150,142,000USD
Short Term Debt55,422,000USD55,674,000USD55,046,000USD17,819,000USD17,950,000USD15,279,000USD20,795,000USD22,475,000USD
Short Long Term Debt47,865,000USD47,865,000USD47,865,000USD12,500,000USD12,500,000USD9,375,000USD15,000,000USD17,000,000USD
Short Long Term Debt Total1,065,192,000USD1,078,130,000USD1,087,243,000USD447,590,000USD451,350,000USD471,839,000USD475,819,000USD475,452,000USD
Long Term Debt979,764,000USD990,904,000USD1,002,026,000USD401,057,000USD403,894,000USD425,299,000USD423,119,000USD425,006,000USD
Long Term Investments27,257,000USD28,533,000USD27,358,000USD47,350,000USD46,901,000USD48,215,000USD43,525,000USD42,172,000USD
Net Receivables500,070,000USD407,575,000USD397,019,000USD365,278,000USD328,645,000USD324,802,000USD226,136,000USD225,239,000USD
Accounts Payable54,328,000USD44,842,000USD58,499,000USD14,329,000USD14,911,000USD15,168,000USD36,908,000USD38,221,000USD
Property Plant Equipment Net93,479,000USD94,431,000USD90,100,000USD48,431,000USD47,547,000USD46,875,000USD45,291,000USD39,097,000USD
Property Plant Equipment Gross93,479,000USD122,744,000USD90,100,000USD48,431,000USD47,547,000USD71,563,000USD45,291,000USD39,097,000USD
Common Stock Shares Outstanding49,054,135shares49,527,521shares49,470,677shares49,470,677shares48,850,666shares47,929,872shares48,223,788shares47,978,491shares
Non Current Assets Total1,354,727,000USD1,355,348,000USD1,353,557,000USD713,198,000USD717,986,000USD716,398,000USD688,386,000USD683,322,000USD
Non Current Liabilities Total1,036,002,000USD1,045,054,000USD1,052,532,000USD444,658,000USD452,282,000USD475,118,000USD465,341,000USD463,950,000USD
Non Current Liabilities Other18,833,000USD17,107,000USD15,906,000USD12,294,000USD14,685,000USD14,003,000USD7,460,000USD7,723,000USD
Non Currrent Assets Other48,092,000USD100,368,000USD37,200,000USD94,763,000USD95,236,000USD95,992,000USD80,751,000USD26,032,000USD
Net Working Capital258,731,000USD248,040,000USD253,699,000USD269,406,000USD252,002,000USD272,888,000USD284,062,000USD260,524,000USD
Unclassified Non Current Assets53,982,000USD—50,573,000USD-322,840,000USD—-12,116,000USD—50,209,000USD
Unclassified Current Liabilities-45,358,000USD-47,865,000USD-47,865,000USD-12,500,000USD-12,500,000USD-9,375,000USD-15,000,000USD-17,000,000USD
Unclassified Non Current Liabilities37,405,000USD37,043,000USD34,600,000USD31,307,000USD33,703,000USD35,816,000USD34,762,000USD31,221,000USD
Unclassified Equity477,459,000USD470,814,000USD472,959,000USD463,154,000USD452,390,000USD426,341,000USD411,286,000USD401,638,000USD
Current Deferred Revenue—2,659,000USD——686,000USD1,606,000USD2,246,000USD2,618,000USD
Short Term Investments——1,221,000USD2,417,000USD2,397,000USD2,378,000USD2,354,000USD2,383,000USD
Other Assets———322,840,000USD—-20,657,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets2,218,661,000USD1,354,894,000USD933,361,000USD966,213,000USD867,361,000USD817,486,000USD728,713,000USD512,999,049USD
Intangible Assets270,968,000USD118,179,000USD71,648,000USD76,861,000USD82,807,000USD86,985,000USD103,012,000USD86,875,883USD
Other Current Assets26,264,000USD22,861,000USD17,450,000USD14,798,000USD18,637,000USD16,797,000USD10,390,000USD7,385,098USD
Total Liab1,660,327,000USD840,726,000USD522,593,000USD407,666,000USD356,719,000USD372,338,000USD367,653,000USD106,337,868USD
Total Stockholder Equity779,291,000USD712,720,000USD614,218,000USD542,561,000USD448,167,000USD330,824,000USD191,549,000USD180,545,832USD
Other Current Liab512,098,000USD322,514,000USD184,102,000USD128,542,000USD88,513,000USD74,058,000USD72,496,000USD46,750,009USD
Common Stock49,000USD48,000USD47,000USD47,000USD45,000USD42,000USD36,000USD34,578USD
Capital Stock49,000USD48,000USD47,000USD47,000USD45,000USD42,000USD35,908USD34,578USD
Retained Earnings308,379,000USD286,283,000USD243,134,000USD182,417,000USD137,246,000USD69,771,000USD31,905,000USD17,788,203USD
Good Will863,944,000USD419,253,000USD278,831,000USD269,053,000USD246,416,000USD239,053,000USD238,505,000USD185,805,880USD
Cash429,474,000USD288,455,000USD293,807,000USD288,027,000USD233,097,000USD193,470,000USD103,189,000USD106,891,503USD
Cash And Short Term Investments429,474,000USD290,833,000USD296,305,000USD293,594,000USD286,514,000USD261,165,000USD219,728,000USD108,018,605USD
Total Current Assets863,313,000USD638,496,000USD461,507,000USD428,125,000USD404,460,000USD338,577,000USD329,068,000USD172,862,792USD
Total Current Liabilities615,273,000USD365,608,000USD218,674,000USD148,610,000USD114,719,000USD114,992,000USD105,424,000USD72,019,647USD
Current Deferred Revenue2,659,000USD1,606,000USD744,000USD531,000USD16,798,000USD12,988,000USD8,892,000USD9,024,235USD
Net Debt648,656,000USD183,384,000USD27,207,000USD-58,663,000USD-32,114,000USD67,085,000USD153,364,000USD-93,232,244USD
Short Term Debt55,674,000USD15,279,000USD24,753,000USD4,785,000USD3,895,000USD14,168,000USD12,593,000USD141,998USD
Short Long Term Debt47,865,000USD9,375,000USD19,500,000USD619,000USD780,000USD10,889,000USD9,500,000USD40,257USD
Short Long Term Debt Total1,078,130,000USD471,839,000USD321,014,000USD229,364,000USD200,983,000USD260,555,000USD256,553,000USD13,659,259USD
Long Term Debt990,904,000USD425,299,000USD258,939,000USD203,389,000USD182,917,000USD230,211,000USD232,172,134USD13,000,000USD
Long Term Investments28,533,000USD48,215,000USD32,170,000USD40,299,000USD42,611,000USD47,917,000USD28,427,455USD52,376,980USD
Net Receivables407,575,000USD324,802,000USD147,752,000USD119,733,000USD99,309,000USD60,615,000USD98,950,000USD57,459,089USD
Accounts Payable44,842,000USD15,168,000USD9,075,000USD10,473,000USD5,513,000USD9,554,000USD6,914,000USD4,481,544USD
Property Plant Equipment Net94,431,000USD46,875,000USD44,567,000USD128,980,000USD68,627,000USD48,464,000USD26,378,000USD12,721,082USD
Property Plant Equipment Gross122,744,000USD71,563,000USD67,443,000USD128,980,000USD68,627,000USD48,464,000USD26,377,628USD12,721,082USD
Common Stock Shares Outstanding49,369,685shares48,223,788shares47,067,442shares45,602,415shares45,403,085shares37,448,430shares36,403,279shares37,914,886shares
Non Current Assets Total1,355,348,000USD716,398,000USD471,854,000USD538,088,000USD462,901,000USD478,909,000USD399,645,000USD340,136,257USD
Non Current Liabilities Total1,045,054,000USD475,118,000USD303,919,000USD259,056,000USD242,000,000USD257,346,000USD262,229,000USD34,318,220USD
Non Current Liabilities Other17,107,000USD14,003,000USD3,586,000USD41,450,000USD14,777,000USD16,176,000USD11,788,116USD14,185,025USD
Non Currrent Assets Other100,368,000USD63,219,000USD2,222,000USD4,556,000USD22,440,000USD19,415,000USD2,427,000USD1,205,962USD
Net Working Capital248,040,000USD272,888,000USD242,833,000USD287,809,000USD283,411,000USD223,585,000USD223,644,503USD100,843,145USD
Unclassified Current Liabilities-47,865,000USD—-19,500,000USD3,660,000USD—-6,665,000USD-4,971,000USD11,581,604USD
Unclassified Non Current Liabilities37,043,000USD35,816,000USD41,394,000USD-12,127,000USD11,275,000USD-10,959,000USD-18,270,146USD-33,283,700USD
Unclassified Equity470,814,000USD426,341,000USD370,990,000USD360,050,000USD310,831,000USD260,969,000USD175,595,268USD176,689,439USD
Other Assets—417,695,000USD22,142,000USD6,056,000USD6,497,000USD55,286,000USD2,426,793USD19,451,432USD
Short Term Investments—2,378,000USD2,498,000USD5,567,000USD53,417,000USD67,695,000USD116,539,000USD1,127,102USD
Unclassified Non Current Assets—-397,038,000USD20,274,000USD12,283,000USD-6,497,000USD-18,211,000USD—-18,300,962USD
Deferred Long Term Liab———3,042,000USD9,127,000USD10,959,000USD18,269,448USD19,615,935USD
Other Liab———23,302,000USD23,904,000USD10,959,000USD18,269,448USD20,800,960USD
Net Tangible Assets———213,968,000USD118,704,000USD119,023,000USD18,756,482USD132,981,098USD
Inventory————-67,217,000USD———
Accumulated Other Comprehensive Income——————-16,023,176USD-14,000,966USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income14,436,000USD6,562,000USD1,077,000USD10,216,000USD6,221,000USD-7,777,000USD23,703,000USD21,866,000USD
Depreciation15,479,000USD16,401,000USD15,596,000USD6,903,000USD6,849,000USD8,126,000USD7,264,000USD7,441,000USD
Stock Based Compensation9,895,000USD11,382,000USD7,700,000USD11,708,000USD7,811,000USD15,235,000USD6,163,000USD7,390,000USD
Other Non Cash Items-149,000USD1,355,000USD3,992,000USD4,824,000USD4,114,000USD-349,000USD-38,921,000USD-547,000USD
Change In Working Capital26,488,000USD-39,223,000USD-15,446,000USD58,852,000USD-8,010,000USD-29,530,000USD36,109,000USD-12,951,000USD
Total Cash From Operating Activities68,056,000USD-2,886,000USD9,956,000USD90,900,000USD16,627,000USD-10,948,000USD33,981,000USD23,188,000USD
Capital Expenditures-4,000,000USD-3,064,000USD-2,552,000USD-1,420,000USD-3,070,000USD-2,531,000USD-2,295,000USD-2,836,000USD
Free Cash Flow64,056,000USD-5,950,000USD7,404,000USD89,480,000USD13,557,000USD-13,479,000USD31,686,000USD20,352,000USD
Total Cashflows From Investing Activities-2,844,000USD-1,057,000USD-534,471,000USD-1,049,000USD-2,394,000USD-33,324,000USD-8,107,000USD-79,925,000USD
Net Borrowings-11,967,000USD-11,966,000USD655,334,000USD-2,978,000USD-16,379,000USD-3,886,000USD-2,195,000USD—
Total Cash From Financing Activities-15,960,000USD-26,337,000USD648,491,000USD-8,666,000USD-44,170,000USD-15,267,000USD-3,190,000USD47,252,000USD
Dividends Paid-104,000USD-1,556,000USD-96,000USD-778,000USD-5,455,000USD-1,922,000USD-218,000USD-1,801,000USD
Sale Purchase Of Stock-2,906,000USD-15,429,000USD-509,000USD1,316,000USD-1,316,000USD-220,000USD-717,000USD-3,584,000USD
Change In Cash48,909,000USD-30,281,000USD122,524,000USD81,186,000USD-29,937,000USD-59,539,000USD22,684,000USD-9,485,000USD
Begin Period Cash Flow429,474,000USD464,326,000USD339,703,000USD258,517,000USD289,101,000USD348,640,000USD325,956,000USD335,441,000USD
End Period Cash Flow478,383,000USD434,045,000USD462,227,000USD339,703,000USD259,164,000USD289,101,000USD348,640,000USD325,956,000USD
Other Cashflows From Investing Activities1,156,000USD2,058,000USD1,534,000USD419,000USD700,000USD-10,000,000USD-968,000USD-750,000USD
Other Cashflows From Financing Activities-983,000USD2,614,000USD-23,479,000USD-5,925,000USD-21,020,000USD-9,762,000USD112,000USD-3,946,000USD
Unclassified Operating Cash Flow1,907,000USD—-2,963,000USD-1,603,000USD—3,347,000USD——
Change To Account Receivables——9,755,000USD—-9,755,000USD54,672,000USD50,687,000USD-34,324,000USD
Investments——-534,471,000USD-1,077,000USD-2,394,000USD-33,324,000USD-8,107,000USD-79,925,000USD
Unclassified Financing Cash Flow——17,241,000USD————56,583,000USD
Unclassified Investing Cash Flow———1,029,000USD2,370,000USD12,531,000USD3,263,000USD3,586,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
Net Income24,076,000USD49,932,000USD57,849,000USD49,294,000USD122,320,000USD17,673,317USD10,835,002USD25,801,842USD
Depreciation45,749,000USD27,927,000USD17,748,000USD17,517,000USD18,350,000USD18,753,270USD19,303,179USD19,075,353USD
Stock Based Compensation38,601,000USD34,536,000USD22,040,000USD6,745,000USD3,383,000USD1,546,861USD1,441,000USD2,743,116USD
Other Non Cash Items13,556,000USD7,665,000USD6,422,000USD22,852,000USD-102,084,000USD5,272,377USD157,261,463USD42,146,479USD
Change To Account Receivables-7,163,000USD-11,095,000USD-20,568,000USD-21,634,000USD3,011,000USD9,278,497USD-28,626,299USD10,702,753USD
Change In Working Capital-3,098,000USD-63,613,000USD-23,388,000USD-20,121,000USD10,814,000USD-22,771,523USD-63,049,072USD15,982,676USD
Total Cash From Operating Activities114,597,000USD52,198,000USD68,227,000USD70,335,000USD46,163,000USD13,673,383USD26,103,450USD53,073,923USD
Capital Expenditures-10,106,000USD-8,031,000USD-28,529,000USD-19,223,000USD-1,164,000USD-1,041,670USD-1,170,064USD-2,084,769USD
Free Cash Flow104,491,000USD44,167,000USD39,698,000USD51,112,000USD44,999,000USD12,631,713USD24,933,386USD50,989,154USD
Total Cashflows From Investing Activities-538,999,000USD-192,395,000USD-65,523,000USD16,540,000USD95,493,000USD-180,630,636USD-25,762,929USD6,730,789USD
Net Borrowings624,011,000USD152,705,000USD79,171,000USD-57,965,000USD-105,000USD281,351,815USD7,406,131USD4,897,652USD
Total Cash From Financing Activities569,346,000USD135,146,000USD3,421,000USD-47,748,000USD-51,696,000USD163,330,712USD-11,203,643USD-14,975,549USD
Dividends Paid-7,885,000USD-4,036,000USD-62,074,000USD-31,089,000USD-51,319,000USD-61,717,367USD-17,758,808USD-10,447,923USD
Sale Purchase Of Stock-15,429,000USD-937,000USD-10,192,000USD-5,739,000USD-537,000USD-7,569,685USD-5,047,643USD-3,175,836USD
Change In Cash144,944,000USD-5,051,000USD6,125,000USD39,127,000USD89,960,000USD-3,626,541USD-12,880,794USD110,502,287USD
Begin Period Cash Flow289,101,000USD294,152,000USD288,027,000USD193,970,000USD104,010,000USD107,636,973USD119,772,297USD9,270,010USD
End Period Cash Flow434,045,000USD289,101,000USD294,152,000USD233,097,000USD193,970,000USD104,010,432USD106,891,503USD119,772,297USD
Other Cashflows From Investing Activities4,611,000USD-25,744,000USD-23,797,000USD56,000USD-11,304,000USD-49,893,514USD-7,500,000USD26,795,842USD
Other Cashflows From Financing Activities-12,146,000USD-12,586,000USD-3,484,000USD187,480,000USD-1,037,000USD286,979,765USD3,996,357USD-8,410,178USD
Unclassified Operating Cash Flow-4,287,000USD-4,249,000USD-12,444,000USD-5,952,000USD-6,620,000USD-6,800,919USD-99,688,122USD-52,675,543USD
Unclassified Investing Cash Flow-533,504,000USD33,775,000USD52,326,000USD3,342,000USD——6,514,889USD-9,440,001USD
Unclassified Financing Cash Flow-19,205,000USD——-140,435,000USD1,302,000USD-335,713,816USD—2,160,736USD
Investments—-192,395,000USD-65,523,000USD32,365,000USD107,961,000USD-129,695,452USD-23,607,754USD-8,540,283USD
Change To Inventory——12,155,000USD1,025,000USD-5,811,000USD-29,562,909USD-11,756,000USD8,871,489USD
Issuance Of Capital Stock——0USD40,134,000USD-2USD754,998USD200,000USD—
Change To Liabilities———3,217,000USD6,824,000USD-13,879,213USD-10,111,655USD2,362,429USD
Cash And Cash Equivalents Changes———39,127,000USD89,960,000USD-3,626,541USD-10,863,122USD44,924,619USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q1 2026Quarterly · 2026-03-31ProductHealth Care Capitation Revenue892,908,000USD0001193125-26-213157
Q1 2026Quarterly · 2026-03-31ProductHealth Care Other12,486,000USD0001193125-26-213157
Q1 2026Quarterly · 2026-03-31ProductHealth Care Patient Service37,831,000USD0001193125-26-213157
Q1 2026Quarterly · 2026-03-31ProductManagement Service15,685,000USD0001193125-26-213157
Q1 2026Quarterly · 2026-03-31ProductProduct And Service Other6,190,000USD0001193125-26-213157
Q4 2025Quarterly · 2025-12-31ProductHealth Care Capitation Revenue862,814,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductHealth Care Other25,508,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductHealth Care Patient Service39,787,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductManagement Service10,290,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductProduct And Service Other12,124,000USDLegacy provider
FY 2025Yearly · 2025-12-31ProductHealth Care Capitation Revenue2,924,265,000USD0001193125-26-103128
FY 2025Yearly · 2025-12-31ProductHealth Care Other86,199,000USD0001193125-26-103128
FY 2025Yearly · 2025-12-31ProductHealth Care Patient Service112,635,000USD0001193125-26-103128
FY 2025Yearly · 2025-12-31ProductManagement Service30,394,000USD0001193125-26-103128
FY 2025Yearly · 2025-12-31ProductProduct And Service Other28,276,000USD0001193125-26-103128
Q3 2025Quarterly · 2025-09-30ProductHealth Care Capitation Revenue863,380,000USD0001193125-25-274359
Q3 2025Quarterly · 2025-09-30ProductHealth Care Other30,798,000USD0001193125-25-274359
Q3 2025Quarterly · 2025-09-30ProductHealth Care Patient Service40,080,000USD0001193125-25-274359
Q3 2025Quarterly · 2025-09-30ProductManagement Service15,217,000USD0001193125-25-274359
Q3 2025Quarterly · 2025-09-30ProductProduct And Service Other6,573,000USD0001193125-25-274359
Q2 2025Quarterly · 2025-06-30ProductHealth Care Capitation Revenue614,108,000USD0000950170-25-105242
Q2 2025Quarterly · 2025-06-30ProductHealth Care Other15,402,000USD0000950170-25-105242
Q2 2025Quarterly · 2025-06-30ProductHealth Care Patient Service17,878,000USD0000950170-25-105242
Q2 2025Quarterly · 2025-06-30ProductManagement Service2,577,000USD0000950170-25-105242
Q2 2025Quarterly · 2025-06-30ProductProduct And Service Other4,843,000USD0000950170-25-105242
Q1 2025Quarterly · 2025-03-31ProductHealth Care Capitation Revenue583,963,000USD0001193125-26-213157
Q1 2025Quarterly · 2025-03-31ProductHealth Care Other14,491,000USD0001193125-26-213157
Q1 2025Quarterly · 2025-03-31ProductHealth Care Patient Service14,890,000USD0001193125-26-213157
Q1 2025Quarterly · 2025-03-31ProductManagement Service2,310,000USD0001193125-26-213157
Q1 2025Quarterly · 2025-03-31ProductProduct And Service Other4,736,000USD0001193125-26-213157
Q4 2024Quarterly · 2024-12-31ProductHealth Care Capitation Revenue616,900,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductHealth Care Other28,660,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductHealth Care Patient Service7,743,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductManagement Service5,550,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductProduct And Service Other6,356,000USDLegacy provider
FY 2024Yearly · 2024-12-31ProductHealth Care Capitation Revenue1,856,785,000USD0001193125-26-103128
FY 2024Yearly · 2024-12-31ProductHealth Care Other86,224,000USD0001193125-26-103128
FY 2024Yearly · 2024-12-31ProductHealth Care Patient Service62,331,000USD0001193125-26-103128
FY 2024Yearly · 2024-12-31ProductManagement Service13,979,000USD0001193125-26-103128
FY 2024Yearly · 2024-12-31ProductProduct And Service Other15,221,000USD0001193125-26-103128
Q3 2024Quarterly · 2024-09-30ProductHealth Care Capitation Revenue431,401,000USD0001193125-25-274359
Q3 2024Quarterly · 2024-09-30ProductHealth Care Other21,779,000USD0001193125-25-274359
Q3 2024Quarterly · 2024-09-30ProductHealth Care Patient Service18,692,000USD0001193125-25-274359
Q3 2024Quarterly · 2024-09-30ProductManagement Service2,747,000USD0001193125-25-274359
Q3 2024Quarterly · 2024-09-30ProductProduct And Service Other4,091,000USD0001193125-25-274359
Q2 2024Quarterly · 2024-06-30ProductHealth Care Capitation Revenue442,574,000USD0000950170-25-105242
Q2 2024Quarterly · 2024-06-30ProductHealth Care Other18,408,000USD0000950170-25-105242
Q2 2024Quarterly · 2024-06-30ProductHealth Care Patient Service19,959,000USD0000950170-25-105242
Q2 2024Quarterly · 2024-06-30ProductManagement Service1,604,000USD0000950170-25-105242
Q2 2024Quarterly · 2024-06-30ProductProduct And Service Other3,720,000USD0000950170-25-105242
FY 2023Yearly · 2023-12-31ProductHealth Care Capitation Revenue1,215,614,000USD0001193125-26-103128
FY 2023Yearly · 2023-12-31ProductHealth Care Other63,468,000USD0001193125-26-103128
FY 2023Yearly · 2023-12-31ProductHealth Care Patient Service59,658,000USD0001193125-26-103128
FY 2023Yearly · 2023-12-31ProductManagement Service38,677,000USD0001193125-26-103128
FY 2023Yearly · 2023-12-31ProductProduct And Service Other9,244,000USD0001193125-26-103128
FY 2022Yearly · 2022-12-31ProductHealth Care Capitation Revenue930,131,000USD0001628280-24-008024
FY 2022Yearly · 2022-12-31ProductHealth Care Other117,254,000USD0001628280-24-008024
FY 2022Yearly · 2022-12-31ProductHealth Care Patient Service49,517,000USD0001628280-24-008024
FY 2022Yearly · 2022-12-31ProductManagement Service41,094,000USD0001628280-24-008024
FY 2022Yearly · 2022-12-31ProductProduct And Service Other6,167,000USD0001628280-24-008024
FY 2021Yearly · 2021-12-31ProductHealth Care Capitation Revenue593,224,000USD0001628280-24-008024
FY 2021Yearly · 2021-12-31ProductHealth Care Other111,627,000USD0001628280-24-008024
FY 2021Yearly · 2021-12-31ProductHealth Care Patient Service26,564,000USD0001628280-24-008024
FY 2021Yearly · 2021-12-31ProductManagement Service35,959,000USD0001628280-24-008024
FY 2021Yearly · 2021-12-31ProductProduct And Service Other6,541,000USD0001628280-24-008024
FY 2020Yearly · 2020-12-31ProductHealth Care Capitation Revenue557,326,000USD0001628280-23-005871
FY 2020Yearly · 2020-12-31ProductHealth Care Other77,367,000USD0001628280-23-005871
FY 2020Yearly · 2020-12-31ProductHealth Care Patient Service12,683,000USD0001628280-23-005871
FY 2020Yearly · 2020-12-31ProductManagement Service34,850,000USD0001628280-23-005871
FY 2020Yearly · 2020-12-31ProductProduct And Service Other4,954,000USD0001628280-23-005871
FY 2019Yearly · 2019-12-31ProductHealth Care Capitation Revenue454,168,000USD0001628280-22-004291
FY 2019Yearly · 2019-12-31ProductHealth Care Other51,098,000USD0001628280-22-004291
FY 2019Yearly · 2019-12-31ProductHealth Care Patient Service15,475,000USD0001628280-22-004291
FY 2019Yearly · 2019-12-31ProductManagement Service34,668,000USD0001628280-22-004291
FY 2019Yearly · 2019-12-31ProductProduct And Service Other5,209,000USD0001628280-22-004291
FY 2018Yearly · 2018-12-31ProductHealth Care Capitation Revenue344,307,000USD0001628280-21-004679
FY 2018Yearly · 2018-12-31ProductHealth Care Other100,928,000USD0001628280-21-004679
FY 2018Yearly · 2018-12-31ProductHealth Care Patient Service19,704,000USD0001628280-21-004679
FY 2018Yearly · 2018-12-31ProductManagement Service49,743,000USD0001628280-21-004679
FY 2018Yearly · 2018-12-31ProductProduct And Service Other5,226,000USD0001628280-21-004679

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.